Sporegen Limited
08001035
Healthy
No risk factors detected.
Details
Previously known as
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 23/11/2025
Due 07/12/2026
Industry
Officers
Former
director · Resigned 18/01/2017
director · Resigned 18/01/2017
director · Resigned 18/01/2017
corporate secretary · Resigned 19/04/2018
Persons with Significant Control
Dr Simon Michael Cutting
British · United Kingdom · Age 64
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
Notified 06/04/2016
Change History
Active
Private Limited Company
THE LONDON BIOSCIENCE INNOVATION CENTRE
LONDON
CompanyRankvs 81+ SIC 72110 peers84
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2026
Net Worth
£693k
Balance sheet strength
Cash
£467k
Cash in the bank
Net Current Assets
£528k
Working capital
Current Assets
£551k
Current Liabilities
£23k
Fixed Assets
£167k
Debtors
£84k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 23.98 | -£122k |
| 2025 | 21.09 | -£27k |
| 2024 | 35.90 | +£15k |
| 2023 | 153.51 | — |
Derived from filed accounts. Not audited figures.